Janssen Injecting $176 Million into Irish Biomedicines Plant

Janssen Injecting $176 Million into Irish Biomedicines Plant

Janssen Injecting $176 Million into Irish Biomedicines Plant

GALWAY, IRELAND--September 28, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Johnson & Johnson (NYSE:JNJ) (New Brunswick, New Jersey) subsidiary Janssen Sciences Ireland is pumping 150 million euro (US$176 million) into expanding its manufacturing biomedicines facility in Ringaskiddy, County Cork.

Within this article: Details plant expansion, investment, products produced, timeline, previous investment

Subscribe Now!(All Fields Required)

Standard Membership - Free